RxDoctor Payments Data

Syed Amanullah, MD

Psychiatry · Aurora, ILNPI 1922435973

Payments from drug & device makers

$4,228in general payments, 2019–2025

Across 241 payments — averaging $17.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vanda Pharmaceuticals Inc.$874
  • Johnson & Johnson$508
  • Takeda Pharmaceuticals U.S.A., Inc.$481
  • Otsuka America Pharmaceutical, Inc.$480
  • AbbVie$389
  • Corium, LLC$293
  • plus $1K from 18 others

What the payments were for

  • Food & beverage$4,217100%
  • Education$110%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,228 in reported general payments places this provider in the 85th percentile of 1,344 psychiatry providers in Illinois.

See all psychiatry providers in Illinois

Medicare billing

Part B allowed, 2024
$124,837
Medicare patients
223
Services billed
1,403

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate22$248,389
VraylarCariprazine Hcl12$17,086
Aripiprazole117$8,329
VyvanseLisdexamfetamine Dimesylate15$5,899
Bupropion XlBupropion Hcl212$5,287
Divalproex Sodium ErDivalproex Sodium71$4,654
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine79$4,430
Ziprasidone Hcl40$4,301
InvegaPaliperidone11$3,929
Lisdexamfetamine Dimesylate15$3,034
Methylphenidate ErMethylphenidate Hcl24$2,827
Duloxetine Hcl170$2,769
Venlafaxine Hcl ErVenlafaxine Hcl156$2,671
Olanzapine118$2,537
Quetiapine Fumarate96$2,229

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$50$248,38922 claims
AbbVieVraylar$389$17,08612 claims
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse$481$5,89915 claims
Johnson & JohnsonInvega$508$3,92911 claims
Lilly USA, LLCOlanzapine$23$2,537118 claims
Almatica Pharma LLCSertraline Hcl$50$970183 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,344 psychiatry providers in Illinois.

Other psychiatry in Aurora

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →